Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: Progress to date

BioDrugs

Volumn 21, Issue 1, 2007, Pages 9-15

  Chang, Zhijie ^a   Babiuk, Lorne A ^b   Hu, Jim ^c,d  

^a Tsinghua University   (China)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIINFLAMMATORY AGENT; DOUBLE STRANDED RNA; DRUG CARRIER; ICS 283; INTERLEUKIN 8; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MACACA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

HUMANS; RNA, SMALL INTERFERING; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33846932835     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200721010-00002     Document Type: Review

References (50)

1. Parry J. SARS virus identified, but the disease is still spreading. BMJ 2003 Apr 26; 326 (7395): 897
2. Skowronski DM, Astell C, Brunham RC, et al. Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005; 56: 357-81
3. Cinatl J Jr, Michaelis M, Hoever G, et al. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 2005 Jun; 66 (2-3): 81-97
4. Holmes KV. SARS-associated coronavirus. N Engl J Med 2003 May 15; 348 (20): 1948-51
5. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 May 15; 348 (20): 1967-76
6. Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis 2005 Jul; 11 (7): 1016-20
7. Zhi Y, Wilson JM, Shen H. SARS vaccine: progress and challenge. Cell Mol Immunol 2005 Apr; 2 (2): 101-5
8. Taylor DR. Obstacles and advances in SARS vaccine development. Vaccine 2006 Feb 13; 24 (7): 863-71
9. Kesel AJ. Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS). Curr Med Chem 2005; 12 (18): 2095-162
10. Chang Z, Hu J. RNAi therapeutics: Can siRNAs conquer SARS? Gene Ther 2006 Jun; 13 (11): 871-2
11. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003 May 30; 300 (5624): 1399-404
12. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998 Feb 19; 391 (6669): 806-11
13. Sharp PA. RNA interference: 2001. Genes Dev 2001 Mar 1; 15 (5): 485-90
14. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003 Jan; 19 (1): 9-12
15. Braasch DA, Jensen S, Liu Y, et al. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 2003 Jul 8; 42 (26): 7967-75
16. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003 Jun; 4 (6): 457-67
17. Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 2002 Apr 16; 99 (8): 5515-20
18. Pai SI, Lin YY, Macaes B, et al. Prospects of RNA interference therapy for cancer. Gene Ther 2006 Mar; 13 (6): 464-77
19. Wu CJ, Chan YL. Antiviral applications of RNAi for coronavirus. Expert Opin Investig Drugs 2006 Feb; 15 (2): 89-97
20. He ML, Zheng B, Peng Y, et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA 2003 Nov 26; 290 (20): 2665-6
21. Zhang R, Guo Z, Lu J, et al. Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA. Chin Med J (Engl) 2003 Aug; 116 (8): 1262-4
22. Zhang Y, Li T, Fu L, et al. Silencing SARS-CoV spike protein expression in cultured cells by RNA interference. FEBS Lett 2004 Feb 27; 560 (1-3): 141-6
23. Wang Z, Ren L, Zhao X, et al. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J Virol 2004 Jul; 78 (14): 7523-7
24. Li T, Zhang Y, Fu L, et al. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. Gene Ther 2005 May; 12 (9): 751-61
25. Qin ZL, Zhao P, Zhang XL, et al. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells. Biochem Biophys Res Commun 2004 Nov 26; 324 (4): 1186-93
26. Lu A, Zhang H, Zhang X, et al. Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. Virology 2004 Jun 20; 324 (1): 84-9
27. Wu CJ, Huang HW, Liu CY, et al. Inhibition of SARS-CoV replication by siRNA. Antiviral Res 2005 Jan; 65 (1): 45-8
28. Ni B, Shi X, Li Y, et al. Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA. Antivir Ther 2005; 10 (4): 527-33
29. Zhao P, Qin ZL, Ke JS, et al. Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. FEBS Lett 2005 Apr 25; 579 (11): 2404-10
30. Shi Y, Yang de H, Xiong J, et al. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res 2005 Mar; 15 (3): 193-200
31. Zheng BJ, Guan Y, Tang Q, et al. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antivir Ther 2004 Jun; 9 (3): 365-74
32. Li BJ, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005 Sep; 11 (9): 944-51
33. He ML, Zheng BJ, Chen Y, et al. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. FEBS Lett 2006 May 1; 580 (10): 2414-20
34. Elmen J, Thonberg H, Ljungberg K, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res 2005; 33 (1): 439-47
35. Meng B, Lui YW, Meng S, et al. Identification of Effective siRNA blocking the expression of SARS viral envelope E and RDRP genes. Mol Biotechnol 2006 Jun; 33 (2): 141-8
36. Ruan YJ, Wei CL, Ee AL, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003 May 24; 361 (9371): 1779-85
37. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003 Oct 17; 115 (2): 209-16
38. Schwarz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003 Oct 17; 115 (2): 199-208
39. Aronin N. Target selectivity in mRNA silencing. Gene Ther 2006 Mar; 13 (6): 509-16
40. Poon LL, Leung CS, Chan KH, et al. Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates. J Med Virol 2005 Aug; 76 (4): 435-40
41. Wu HL, Huang LR, Huang CC, et al. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 2005 Mar; 128 (3): 708-16
42. Bridge AJ, Pebernard S, Ducraux A, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet 2003; 34 (3): 263-4
43. Grimm D, Streetz KL, Jopling CL, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006; 441 (7092): 537-41
44. Koehler DR, Hitt MM, Hu J. Challenges and strategies for cystic fibrosis lung gene therapy. Mol Ther 2001 Aug; 4 (2): 84-91
45. Koehler DR, Sajjan U, Chow YH, et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc Natl Acad Sci U S A 2003 Dec 23; 100 (26): 15364-9
46. Koehler DR, Frndova H, Leung K, et al. Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med 2005 Nov; 7 (11): 1409-20
47. Koehler DR, Martin B, Corey M, et al. Readministration of helper-dependent adenovirus to mouse lung. Gene Ther 2006 May; 13 (9): 773-80
48. Cao HB, Wang A, Martin B, et al. Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference. Cell Res 2005 Feb; 15 (2): 111-9
49. Schiffelers RM, Storm G. ICS-283: a system for targeted intravenous delivery of siRNA. Expert Opin Drug Deliv 2006 May; 3 (3): 445-54
50. Dykxhoorn DM, Lieberman J. Knocking down disease with siRNAs. Cell 2006 Jul 28; 126 (2): 231-5